piracetam has been researched along with heme in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bel'skaya, GN; Derev'yannykh, EA; Knoll, EA; Krylova, LG; Popov, DV | 1 |
| Konoplya, AI; Laskov, VB; Shul'ginova, AA | 1 |
2 other study(ies) available for piracetam and heme
| Article | Year |
|---|---|
Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
Topics: Aged; Brain Ischemia; Central Nervous System Stimulants; Cerebral Infarction; Cerebrovascular Circulation; Cognition Disorders; Electroencephalography; Female; Heme; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Piracetam; Stroke; Tomography, X-Ray Computed | 2008 |
[Immune and oxygen disturbances in patients with chronic cerebral ischemia and their correction].
Topics: Adult; Amino Acids; Antioxidants; Brain Ischemia; C-Reactive Protein; Chronic Disease; Complement C1 Inhibitor Protein; Complement Factor H; Complement System Proteins; Cytokines; Drug Therapy, Combination; Female; Heme; Humans; Hydrogen Peroxide; Immunoglobulins; Male; Malondialdehyde; Middle Aged; Nootropic Agents; Picolines; Piracetam | 2015 |